Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Singapore | EU Health & Wellness

Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Singapore

10021

Apretude is a revolutionary long-acting injectable PrEP designed to reduce the risk of HIV infection, offering an effective prevention option.

Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Singapore

Apretude is a revolutionary long-acting injectable PrEP designed to reduce the risk of HIV infection, offering an effective prevention option.